toggle visibility Search & Display Options

Select All    Deselect All
 |   | 

Deprecated: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in /home/acutrialsocom/public_html/refbase-ocom/includes/ on line 5275
  Record Links
Author (up) Aydogmus, Y.; Sunay, M.; Arslan, H.; Aydin, A.; Adiloglu, A. K.; Sahin, H. url  doi
  Title Acupuncture versus Solifenacin for Treatment of Overactive Bladder and Its Correlation with Urine Nerve Growth Factor Levels: A Randomized, Placebo-Controlled Clinical Trial Type of Study RCT
  Year 2014 Publication Urologia internationalis Abbreviated Journal Urol Int  
  Volume Issue Pages -  
  Keywords RCT; Urologic Diseases; Urinary Bladder, Overactive; Urgency; Urinary Frequency; Acu Versus > 1 Control; Acupuncture; TCM Acupuncture Style; Fixed Acupuncture Protocol; Restricted Modalities, Acupuncture Only; Usual Care Control, Pharmaceutical; Sham Control; Non Penetrating Sham, Mechanical; Verum Acupoint Control  
  Abstract Objective: To determine whether acupuncture is effective as an overactive bladder (OAB) treatment compared with solifenacin and placebo, and to investigate its relation with urine nerve growth factor (NGF) levels. Patients and Methods: The study was conducted with methodological rigor based on the Consolidated Standards of Reporting Trials criteria. 90 female patients with OAB were included and randomly assigned to a solifenacin, acupuncture or placebo group. The medicated group received solifenacin 5 mg/day; the acupuncture and placebo groups were treated twice a week for 4 weeks. Symptom scores, quality of life scores, frequency of micturition and urine NGF levels were used to assess treatment efficiency. Results: The study was completed with 82 patients (n = 30 in the solifenacin group, n = 28 in the acupuncture group and n = 24 in the placebo group). After treatment, comparison of the medical and acupuncture therapy groups with the placebo group showed significant differences between recovery concerning quality of life (p < 0.001 and p < 0.01, respectively) and symptom scores (p < 0.001 and p < 0.001, respectively). The decrease of NGF levels after treatment compared to before treatment was determined in each group (solifenacin, acupuncture, placebo group; p < 0.001, p < 0.001, p = 0.359, respectively). Sufficient symptomatic improvement was not achieved in 8 patients in the acupuncture group. Therefore, comparisons were assessed twice with and without including these patients, and NGF levels in the acupuncture group were higher than at first comparison in which all patients in the acupuncture group were included. Conclusions: In patients with OAB in whom anticholinergic treatment is contraindicated, acupuncture may be considered another treatment option. (c) 2014 S. Karger AG, Basel.  
  Address Clinic of Urology, Department of Acupuncture and Department of Microbiology, Ministry of Health Ankara Training and Research Hospital, Ankara, Turkey.  
  Language Number of Treatments 8  
  Treatment Follow-up N/A Frequency >1/WK Number of Participants 90  
  Time in Treatment 4 Weeks Condition Urinary Bladder, Overactive
  Disease Category Urologic Diseases OCSI Score  
  Notes Approved no  
  Call Number Serial 49  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: